Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.
暂无分享,去创建一个
B. Gazzard | L. Waters | M. Nelson | M. Bower | S. Mandalia | J. Stebbing
[1] Michael S Saag,et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.
[2] Michael S Saag,et al. Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel , 2006 .
[3] R. Hershow,et al. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] K. Sherman,et al. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. , 2005, The Journal of infectious diseases.
[5] C. Hung,et al. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection , 2005, International journal of STD & AIDS.
[6] E. Daar,et al. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. , 2005, The Journal of infectious diseases.
[7] D. Vlahov,et al. The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy , 2004, AIDS.
[8] J. Guest,et al. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] N. Voirin,et al. Survival in HIV‐infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database , 2004, Journal of viral hepatitis.
[10] B. Gazzard,et al. Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients , 2004, Cell Research.
[11] K. Ruxrungtham,et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort , 2004, AIDS.
[12] D. Pillay,et al. HIV and hepatitis C coinfection within the CAESAR study , 2004, HIV medicine.
[13] B. Gazzard,et al. Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. , 2004, Blood.
[14] Martin S. Hirsch,et al. Treatment for adult HIV infection. , 2004 .
[15] P. Morlat,et al. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) , 2003, AIDS.
[16] E. Ribera,et al. Hepatitis C virus and human immunodeficiency virus coinfection in Spain. , 2003, The Journal of infection.
[17] Y. Lo,et al. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. , 2003, Journal of acquired immune deficiency syndromes.
[18] S. Suissa,et al. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. , 2003, Journal of acquired immune deficiency syndromes.
[19] D. Dieterich,et al. Toxicity of non-nucleoside analogue reverse transcriptase inhibitors. , 2003, Seminars in liver disease.
[20] M. Sulkowski. Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors , 2003, Seminars in liver disease.
[21] A. Moorman,et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] J. Macías,et al. Mortality due to Liver Failure and Impact on Survival of Hepatitis Virus Infections in HIV-Infected Patients Receiving Potent Antiretroviral Therapy , 2002, European Journal of Clinical Microbiology and Infectious Diseases.
[23] P. Easterbrook,et al. Hepatitis C and HIV-1 coinfection , 2002, Gut.
[24] George Y Wu,et al. Hepatitis C and HIV co-infection: a review. , 2002, World journal of gastroenterology.
[25] Richard D Moore,et al. Hepatitis C and progression of HIV disease. , 2002, JAMA.
[26] P. Volberding,et al. Does hepatitis C virus infection increase the risk of HIV disease progression? , 2002, JAMA.
[27] P. Couzigou,et al. Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? , 2002, AIDS.
[28] A. Gervais. [Chronic hepatitis C in HIV-HCV coinfected patients]. , 2002, Gastroenterologie clinique et biologique.
[29] I. Bica,et al. Risk of HAART therapy in hepatitis C , 2002, Hepatology.
[30] R. Chaisson,et al. Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: Role of hepatitis C and B infections , 2002, Hepatology.
[31] Harpreet K. Monga,et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] M. Battegay,et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study , 2000, The Lancet.
[33] D. Vlahov,et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. , 2000, JAMA.
[34] C. Tsoukas,et al. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. , 1999, The Journal of infectious diseases.
[35] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[36] S. Darby,et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C , 1997, The Lancet.
[37] C. Sabin,et al. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. , 1997, The Journal of infectious diseases.
[38] A. Phillips,et al. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. , 1995, The Journal of infectious diseases.
[39] P. Bacchetti,et al. Hepatitis C in HIV‐infected patients with and without AIDS: Prevalence and relationship to patient survival , 1994, Hepatology.
[40] M. Krajden,et al. Hepatitis C virus infection in patients infected with the human immunodeficiency virus. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.